Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, CA / ACCESS Newswire / January 12, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...
Bleeding Cool

X-Men: Age of Revelation Finale #1 Preview: Revelation's Soft Side?

X-Men: Age of Revelation Finale #1 hits stores this New Year's Eve! Revelation claims he's motivated by love, not power.

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting

"I would like to thank all those that have voted for the December 3, 2025, Special Meeting and remind all those who have not yet voted to vote," said James Rolke, Chief Executive Officer, Revelation.
Bleeding Cool

X-Men Post-Age Of Revelation in The Daily LITG, 31st December 2025

How X-Men Will Be Looking Post-Age Of Revelation With Magik & Colossus was the most-read story on Bleeding Cool yesterday.